Omnitura Therapeutics, Inc.
Get Full AccessDescription
- Omnitura Therapeutics is a clinical stage company that is commercializing Aneustat, the world's first multivalent immuno-oncology drug candidate. Aneustat has successfully completed a phase I/IIa clinical trial in cancer patients and is now entering phase II clinical trials for prostate cancer. For more information, please visit www.omnitura.com.
-
Headquarters:2830 Forest Grove Drive , Burlingame, California, United States
More -
Phone Number: +1 650-627-9455
-
Website: https://www.omnitura.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Omnitura Therapeutics, Inc.
-
Omnitura Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Omnitura Therapeutics, Inc.
-
Where are Omnitura Therapeutics, Inc.'s Headquarters?
Omnitura Therapeutics, Inc.'s Headquarters are in 2830 Forest Grove Drive ,Burlingame,California,United States
-
What is Omnitura Therapeutics, Inc.'s phone number?
Omnitura Therapeutics, Inc.'s phone number is +1 650-627-9455
-
What is Omnitura Therapeutics, Inc.'s official website?
Omnitura Therapeutics, Inc.'s official website is https://www.omnitura.com
-
What is Omnitura Therapeutics, Inc.'s Revenue?
Omnitura Therapeutics, Inc.'s revenue is $1 - 10M
-
What is Omnitura Therapeutics, Inc.'s NAICS code?
Omnitura Therapeutics, Inc.'s NAICS code is 541713
-
How many employees are working in Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. has 6 employees
-
What is Omnitura Therapeutics, Inc.'s Industry?
Omnitura Therapeutics, Inc. is in the industry of Pharmaceuticals
-
Who is Omnitura Therapeutics, Inc.'s Board Member?
Omnitura Therapeutics, Inc.'s Board Member is Lee Ting